U.S. markets closed

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
739.51+32.38 (+4.58%)
At close: 4:03PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 7/30/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 333.16%
S&P500 52-Week Change 334.13%
52 Week High 3756.52
52 Week Low 3472.84
50-Day Moving Average 3654.78
200-Day Moving Average 3611.20

Share Statistics

Avg Vol (3 month) 3126.45k
Avg Vol (10 day) 3100.06k
Shares Outstanding 524.69M
Implied Shares Outstanding 629.76M
Float 21.35M
% Held by Insiders 114.27%
% Held by Institutions 181.19%
Shares Short (Jul 14, 2021) 4602.78k
Short Ratio (Jul 14, 2021) 45.48
Short % of Float (Jul 14, 2021) 42.85%
Short % of Shares Outstanding (Jul 14, 2021) 42.03%
Shares Short (prior month Jun 14, 2021) 4551.23k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Mar 07, 2002

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021


Profit Margin 140.48%
Operating Margin (ttm)17.65%

Management Effectiveness

Return on Assets (ttm)2.52%
Return on Equity (ttm)42.70%

Income Statement

Revenue (ttm)2.88B
Revenue Per Share (ttm)96.76
Quarterly Revenue Growth (yoy)33.40%
Gross Profit (ttm)1.44B
EBITDA 643.49M
Net Income Avi to Common (ttm)4.05B
Diluted EPS (ttm)135.92
Quarterly Earnings Growth (yoy)-5.40%

Balance Sheet

Total Cash (mrq)1.17B
Total Cash Per Share (mrq)39.1
Total Debt (mrq)12.52M
Total Debt/Equity (mrq)0.11
Current Ratio (mrq)3.90
Book Value Per Share (mrq)389.57

Cash Flow Statement

Operating Cash Flow (ttm)688.63M
Levered Free Cash Flow (ttm)529.48M